Essex Bio-Technology Investor Relations Material
Latest events
H2 2024
26 Mar, 2025
H1 2024
25 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Essex Bio-Technology Limited
Access all reports
Essex Bio-Technology Limited is a biopharmaceutical company engaged in the research, development, manufacturing, and marketing of therapeutic products. The company focuses on regenerative medicine and specializes in biopharmaceutical drugs for ophthalmology and wound care. Its product portfolio includes formulations derived from recombinant DNA technology and other biological sources. Essex Bio-Technology Limited conducts its operations through integrated facilities that support clinical research, production, and distribution. The company is headquartered in Hong Kong, China, and its shares are listed on the HKEX.
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
1061
Country
🇭🇰 Hong Kong